Literature DB >> 26121073

The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.

Sarah A Sterling1, W Ryan Miller, Jason Pryor, Michael A Puskarich, Alan E Jones.   

Abstract

OBJECTIVES: We sought to systematically review and meta-analyze the available data on the association between timing of antibiotic administration and mortality in severe sepsis and septic shock. DATA SOURCES: A comprehensive search criteria was performed using a predefined protocol. INCLUSION CRITERIA: adult patients with severe sepsis or septic shock, reported time to antibiotic administration in relation to emergency department triage and/or shock recognition, and mortality. EXCLUSION CRITERIA: immunosuppressed populations, review article, editorial, or nonhuman studies. DATA EXTRACTION: Two reviewers screened abstracts with a third reviewer arbitrating. The effect of time to antibiotic administration on mortality was based on current guideline recommendations: 1) administration within 3 hours of emergency department triage and 2) administration within 1 hour of severe sepsis/septic shock recognition. Odds ratios were calculated using a random effect model. The primary outcome was mortality. DATA SYNTHESIS: A total of 1,123 publications were identified and 11 were included in the analysis. Among the 11 included studies, 16,178 patients were evaluable for antibiotic administration from emergency department triage. Patients who received antibiotics more than 3 hours after emergency department triage (< 3 hr reference) had a pooled odds ratio for mortality of 1.16 (0.92-1.46; p = 0.21). A total of 11,017 patients were evaluable for antibiotic administration from severe sepsis/septic shock recognition. Patients who received antibiotics more than 1 hour after severe sepsis/shock recognition (< 1 hr reference) had a pooled odds ratio for mortality of 1.46 (0.89-2.40; p = 0.13). There was no increased mortality in the pooled odds ratios for each hourly delay from less than 1 to more than 5 hours in antibiotic administration from severe sepsis/shock recognition.
CONCLUSION: Using the available pooled data, we found no significant mortality benefit of administering antibiotics within 3 hours of emergency department triage or within 1 hour of shock recognition in severe sepsis and septic shock. These results suggest that currently recommended timing metrics as measures of quality of care are not supported by the available evidence.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26121073      PMCID: PMC4597314          DOI: 10.1097/CCM.0000000000001142

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  25 in total

1.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

Review 2.  Clinical implications of antibiotic-induced endotoxin release in septic shock.

Authors:  P M Lepper; T K Held; E M Schneider; E Bölke; H Gerlach; M Trautmann
Journal:  Intensive Care Med       Date:  2002-05-30       Impact factor: 17.440

3.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Authors:  Anand Kumar; Daniel Roberts; Kenneth E Wood; Bruce Light; Joseph E Parrillo; Satendra Sharma; Robert Suppes; Daniel Feinstein; Sergio Zanotti; Leo Taiberg; David Gurka; Aseem Kumar; Mary Cheang
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

4.  Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock.

Authors:  Alan E Jones; Anne Focht; James M Horton; Jeffrey A Kline
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

5.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  J Clin Epidemiol       Date:  2009-07-23       Impact factor: 6.437

6.  Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality.

Authors:  H Bryant Nguyen; Stephen W Corbett; Robert Steele; Jim Banta; Robin T Clark; Sean R Hayes; Jeremy Edwards; Thomas W Cho; William A Wittlake
Journal:  Crit Care Med       Date:  2007-04       Impact factor: 7.598

7.  Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis.

Authors:  J L Shenep; K A Mogan
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

8.  Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use.

Authors:  J J Kerremans; P Verboom; T Stijnen; L Hakkaart-van Roijen; W Goessens; H A Verbrugh; M C Vos
Journal:  J Antimicrob Chemother       Date:  2007-12-21       Impact factor: 5.790

Review 9.  The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis.

Authors:  Alan E Jones; Michael D Brown; Stephen Trzeciak; Nathan I Shapiro; John S Garrett; Alan C Heffner; Jeffrey A Kline
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

10.  National estimates of severe sepsis in United States emergency departments.

Authors:  Henry E Wang; Nathan I Shapiro; Derek C Angus; Donald M Yealy
Journal:  Crit Care Med       Date:  2007-08       Impact factor: 7.598

View more
  89 in total

1.  Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.

Authors:  Lisa M Daniels; Urshila Durani; Jason N Barreto; John C O'Horo; Mustaqeem A Siddiqui; John G Park; Pritish K Tosh
Journal:  Support Care Cancer       Date:  2019-02-25       Impact factor: 3.603

2.  The authors reply.

Authors:  Sarah A Sterling; Michael A Puskarich; Alan E Jones
Journal:  Crit Care Med       Date:  2016-10       Impact factor: 7.598

3.  The authors reply.

Authors:  Sarah A Sterling; Michael A Puskarich; William R Miller; Alan E Jones
Journal:  Crit Care Med       Date:  2016-10       Impact factor: 7.598

4.  Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.

Authors:  Christa Koenig; Christine Schneider; Jessica E Morgan; Roland A Ammann; Lillian Sung; Bob Phillips
Journal:  Support Care Cancer       Date:  2019-07-01       Impact factor: 3.603

5.  Antibiotic Thresholds for Sepsis and Septic Shock.

Authors:  Marin H Kollef; Jason P Burnham
Journal:  Clin Infect Dis       Date:  2019-08-30       Impact factor: 9.079

6.  Is it time to implement door-to-needle time for "infection attacks"?

Authors:  Kevin B Laupland; Ricard Ferrer
Journal:  Intensive Care Med       Date:  2017-05-02       Impact factor: 17.440

7.  Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial.

Authors:  Frank Bloos; Hendrik Rüddel; Daniel Thomas-Rüddel; Daniel Schwarzkopf; Christine Pausch; Stephan Harbarth; Torsten Schreiber; Matthias Gründling; John Marshall; Philipp Simon; Mitchell M Levy; Manfred Weiss; Andreas Weyland; Herwig Gerlach; Tobias Schürholz; Christoph Engel; Claudia Matthäus-Krämer; Christian Scheer; Friedhelm Bach; Reimer Riessen; Bernhard Poidinger; Karin Dey; Norbert Weiler; Andreas Meier-Hellmann; Helene H Häberle; Gabriele Wöbker; Udo X Kaisers; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2017-05-02       Impact factor: 17.440

8.  Sepsis reconsidered: Identifying novel metrics for behavioral landscape characterization with a high-performance computing implementation of an agent-based model.

Authors:  Chase Cockrell; Gary An
Journal:  J Theor Biol       Date:  2017-07-18       Impact factor: 2.691

9.  Importance of Pharmacy Involvement in the Treatment of Sepsis.

Authors:  Joseph B Cavanaugh; Jesse B Sullivan; Nicole East; Jessica N Nodzon
Journal:  Hosp Pharm       Date:  2017-03

10.  Gold Nanoparticles with Antibiotic-Metallopolymers toward Broad-Spectrum Antibacterial Effects.

Authors:  Peng Yang; Parasmani Pageni; Md Anisur Rahman; Marpe Bam; Tianyu Zhu; Yung Pin Chen; Mitzi Nagarkatti; Alan W Decho; Chuanbing Tang
Journal:  Adv Healthc Mater       Date:  2018-11-27       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.